Molecular Targeted Therapy of Lung Cancer (Post nr. 5464)

MARC-detaljer
000 -LEADER
fixed length control field	03659nam a22004575i 4500
001 - CONTROL NUMBER
control field	60593
005 - DATE AND TIME OF LATEST TRANSACTION
control field	20200226102504.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field	cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field	170127s2017 si \| s \|\|\|\| 0\|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	9789811020025
--	978-981-10-2002-5
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code	10.1007/978-981-10-2002-5
Source of number or code	doi
035 ## - SYSTEM CONTROL NUMBER
System control number	(DE-He213)978-981-10-2002-5
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number	RC705-779
072 #7 - SUBJECT CATEGORY CODE
Subject category code	MJL
Source	bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code	MED079000
Source	bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number	616.2
Edition number	23
245 10 - TITLE STATEMENT
Title	Molecular Targeted Therapy of Lung Cancer
Medium	[electronic resource] /
Statement of responsibility, etc.	edited by Yuichi Takiguchi.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture	Singapore :
Name of producer, publisher, distributor, manufacturer	Springer Singapore :
--	Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice	2017.
300 ## - PHYSICAL DESCRIPTION
Extent	X, 327 p. 54 illus., 48 illus. in color.
Other physical details	online resource.
336 ## - CONTENT TYPE
Content type term	text
Content type code	txt
Source	rdacontent
337 ## - MEDIA TYPE
Media type term	computer
Media type code	c
Source	rdamedia
338 ## - CARRIER TYPE
Carrier type term	online resource
Carrier type code	cr
Source	rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type	text file
Encoding format	PDF
Source	rda
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note	Part I Diagnosis -- 1 Classification of adenocarcinoma of the lung - with a special reference to prognosis -- 2 Screening lung cancer with low dose CT combined with molecular markers -- 3 PET-CT, bio-imaging for predicting prognosis and response to chemotherapy in patients with lung cancer -- 4 Methods in molecular diagnosis -- 5 Accurate nodal staging and biomarker testing with endobronchial ultrasound-guided transbronchial needle aspiration -- 6 Next generation sequencing and bioinformatics -- 7 Companion Diagnostics -- Part II Treatment -- 8 Small cell lung cancer and molecular targeted therapy -- 9 Locally advanced non-small cell lung cancer and molecular targeted therapy -- 10 EGFR mutant -- 11 ALK mutant -- 12 Minor-driver mutant -- 13 Mechanism of resistance to targeted molecular therapy -- 14 Immunotherapy -- 15 Lung cancer complicated with interstitial lung diseases -- 16 Management of adverse effects by molecular targeted therapy and immunotherapy -- Part III Evaluation -- 17 Health related-quality of life in molecular targeted therapy -- 18 Gene signature -- Part IV Novel approach -- 19 Targeting epithelial-mesenchymal transition and cancer stem cell- 20 Targeting the Lung Cancer Microenvironment: Harnessing Host Responses.
520 ## - SUMMARY, ETC.
Summary, etc.	This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety. Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Molecular biology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Respiratory organs
General subdivision	Diseases.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Oncology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Medicine & Public Health.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Pneumology/Respiratory System.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Molecular Medicine.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name	Takiguchi, Yuichi.
Relator term	editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element	SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title	Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information	Printed edition:
International Standard Book Number	9789811020001
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier	<a href="http://dx.doi.org/10.1007/978-981-10-2002-5">http://dx.doi.org/10.1007/978-981-10-2002-5</a>
912 ## -
--	ZDB-2-SME

Inga exemplar finns tillgängliga.